InvestorsHub Logo
Followers 16
Posts 1062
Boards Moderated 0
Alias Born 09/01/2019

Re: Money $hot post# 16363

Friday, 02/03/2023 12:50:16 PM

Friday, February 03, 2023 12:50:16 PM

Post# of 16695
Financing the DMT Trial is from selling 37% of AGNNeuro shares. So Yes, I believe that is a fair deal for AGN shareholders.

COVID was scammed by Phiser/Fousi and even MDNA was pushed aside. All repurposed drugs from several companies were forced to do Trials while Phiser was given a pass and subsidized Trials/research. So inaccurate question IMO., but there are many articles on these subjects.

Ifenprodil did not fail it's CT and there were significant benefits proven including IL-6 for COVID patients and CC reduction / slowing rate of IPF in that 2nd Phase 2 CT for Ifenprodil. i.e. a Phase 2b CT for CC this summer/asap...
I would talk about Cancer But Cancer use for Ifenprodil is another repurposed direction still being applied for ODD/IND status at the FDA and a current CT is not being planned. Maybe later as with the CKD drug. So Yes.
...(I have discussed Cancer in private, confidentially, but I dislike malfeasant sour grapes, so that's over) ....!!

Accusing the AGN CEO of being a drunk is a TOS violation, IMHFO...

If you dont like the company;s format for repurposed drugs then sell the rest of any shares you may still have and move on. I plan to buy more.

Taking comments out of context, ie Shell, is unfair IMO.

You're Buddy...

...GLTA...